Researchers take to space to study cancer drug delivery; Purdue, U.S. Army team up for aneurysm nanotreatment;

 @DamianFierce: Perhaps you can have too much of a good thing. Penn researchers say too many nanocarriers render treatments ineffective. Story | Follow @DamianFierce

> One research team is conducting research on microscale drug delivery for cancer APIs in an uncommon laboratory: the International Space Station. News

> Scientists at the University of Washington and Cornell University have designed three-dimensional, fully functional multivascular networks, allowing for in vitro studies of how drugs interact with vascular systems. Report

> Flexion is celebrating positive Phase IIb results for an intra-articularly delivered osteoarthritis drug, the blockbuster hopeful FX-005. Article

> Purdue and the U.S. Army are working together on nanotechnology-enhanced stents that could treat aneurysms. Story

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.